Thalidomide: near complete regression of extramedullary bulk in refractory multiple myeloma. Swiss Medical Weekly, [S. l.], v. 131, n. 0910, p. 133–133, 2001. DOI: 10.4414/smw.2001.06138. Disponível em: https://smw.ch/index.php/smw/article/view/35. Acesso em: 14 jan. 2026.